FDA APROVAL
Updated
HUMA had a significant decline with DELAY in approval over something minor, still waiting see if it holds the 100MA and gets approval. ANALSYTS PREDICT 11$
Some insider selling and possible dilution. Watching 👀
Some insider selling and possible dilution. Watching 👀
Trade active
Still holding W 100MA. Director buys 4600 shares today at $4.38. Possible further delays in the future
OR approval for strong gap up whispers are word this week either way.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.